MX9302957A - Compuestos de xantina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. - Google Patents
Compuestos de xantina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.Info
- Publication number
- MX9302957A MX9302957A MX9302957A MX9302957A MX9302957A MX 9302957 A MX9302957 A MX 9302957A MX 9302957 A MX9302957 A MX 9302957A MX 9302957 A MX9302957 A MX 9302957A MX 9302957 A MX9302957 A MX 9302957A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- compound
- xantina
- compounds
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Abstract
Se describe un compuesto de fórmula (I): o si es apropiado una sal farmacéuticamente aceptable del mismo, en donde R1 y R2 representan cada uno independientemente una porción de fórmula (a): en donde m representa cero o un número entero 1, 2 ó 3, y A representa un radical hidrocarburo cíclico, substituido o no substituido; R3 representa hidrógeno, alquilo substituido o no substituido, o un grupo aralquilo substituido o no substituido en la porción arilo; y R4 representa hidrógeno, alquilo o alquilcarbonilo; un proceso para la preparación de tal compuesto, una composición farmacéutica que contiene tal compuesto y el uso de tal compuesto en medicina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929210839A GB9210839D0 (en) | 1992-05-21 | 1992-05-21 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9302957A true MX9302957A (es) | 1994-05-31 |
Family
ID=10715834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9302957A MX9302957A (es) | 1992-05-21 | 1993-05-20 | Compuestos de xantina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0641344A1 (es) |
JP (1) | JPH07506591A (es) |
CN (1) | CN1094046A (es) |
AU (1) | AU4081493A (es) |
CA (1) | CA2136196A1 (es) |
GB (1) | GB9210839D0 (es) |
MX (1) | MX9302957A (es) |
TW (1) | TW277062B (es) |
WO (1) | WO1993023401A1 (es) |
ZA (1) | ZA933494B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5684153A (en) | 1984-08-16 | 1997-11-04 | Beecham Group Plc | Process for the preparation of purine derivatives |
GB9623859D0 (en) * | 1996-11-15 | 1997-01-08 | Chiroscience Ltd | Novel compounds |
GB9703044D0 (en) * | 1997-02-14 | 1997-04-02 | Glaxo Group Ltd | Phenyl xanthine esters and amides |
DE69824632T2 (de) | 1997-11-12 | 2005-06-09 | Mitsubishi Chemical Corp. | Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten |
GB9817623D0 (en) | 1998-08-13 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
WO2000068231A1 (fr) | 1999-05-11 | 2000-11-16 | Mitsubishi Chemical Corporation | Dihydrate derive de purine, medicaments le contenant comme principe actif et intermediaire utilise dans sa preparation |
US6403567B1 (en) | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
US6815446B1 (en) | 1999-08-31 | 2004-11-09 | Vanderbilt University | Selective antagonists of A2B adenosine receptors |
JP3914434B2 (ja) * | 1999-08-31 | 2007-05-16 | ヴァンダービルト ユニヴァーシティ | A2bアデノシン受容体の選択的アンタゴニスト |
AU2001238665A1 (en) | 2000-02-23 | 2001-09-03 | Cv Therapeutics, Inc. | Method of identifying partial agonists of the a2a receptor |
US6821978B2 (en) | 2000-09-19 | 2004-11-23 | Schering Corporation | Xanthine phosphodiesterase V inhibitors |
EP1421084B1 (en) | 2001-08-28 | 2008-05-14 | Schering Corporation | Polycyclic guanine phosphodiesterase v inhibitors |
EP1442042A1 (en) | 2001-11-09 | 2004-08-04 | Schering Corporation | Polycyclic guanine derivative phosphodiesterase v inhibitors |
SI1509525T1 (sl) | 2002-05-31 | 2006-12-31 | Schering Corp | Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev |
WO2004009091A1 (en) | 2002-06-17 | 2004-01-29 | Glaxo Group Limited | Purine derivatives as liver x receptor agonists |
US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
US20050020915A1 (en) | 2002-07-29 | 2005-01-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging methods and compositions |
EP1524984A1 (en) | 2002-07-29 | 2005-04-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging using a2a receptor agonists |
CA2533715A1 (en) | 2003-07-31 | 2005-02-10 | Schering Corporation | Metabolite of xanthine phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction |
KR20070083714A (ko) | 2004-10-20 | 2007-08-24 | 씨브이 쎄러퓨틱스, 인코포레이티드 | A2a 아데노신 수용체 작용제의 용도 |
PL1989214T3 (pl) | 2006-02-03 | 2017-07-31 | Gilead Sciences, Inc. | Proces otrzymywania agonisty receptora adenozynowego a2a i jego polimorfów |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2033922T3 (es) * | 1986-08-28 | 1993-04-01 | Sandoz Ag | Procedimiento para preparar nuevos derivados de xantina. |
IT1229195B (it) * | 1989-03-10 | 1991-07-25 | Poli Ind Chimica Spa | Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. |
GB8906792D0 (en) * | 1989-03-23 | 1989-05-10 | Beecham Wuelfing Gmbh & Co Kg | Treatment and compounds |
GB9020959D0 (en) * | 1990-09-26 | 1990-11-07 | Beecham Group Plc | Novel compounds |
GB9020921D0 (en) * | 1990-09-26 | 1990-11-07 | Beecham Group Plc | Novel compounds |
DE69132291T2 (de) * | 1990-12-21 | 2000-12-14 | Beecham Group Plc | Xanthinderivate |
-
1992
- 1992-05-21 GB GB929210839A patent/GB9210839D0/en active Pending
-
1993
- 1993-05-18 CA CA002136196A patent/CA2136196A1/en not_active Abandoned
- 1993-05-18 AU AU40814/93A patent/AU4081493A/en not_active Abandoned
- 1993-05-18 JP JP5520016A patent/JPH07506591A/ja active Pending
- 1993-05-18 WO PCT/GB1993/001014 patent/WO1993023401A1/en not_active Application Discontinuation
- 1993-05-18 EP EP93910221A patent/EP0641344A1/en not_active Withdrawn
- 1993-05-19 ZA ZA933494A patent/ZA933494B/xx unknown
- 1993-05-20 CN CN93107586A patent/CN1094046A/zh active Pending
- 1993-05-20 MX MX9302957A patent/MX9302957A/es unknown
- 1993-06-03 TW TW082104444A patent/TW277062B/zh active
Also Published As
Publication number | Publication date |
---|---|
TW277062B (es) | 1996-06-01 |
AU4081493A (en) | 1993-12-13 |
ZA933494B (en) | 1994-03-01 |
EP0641344A1 (en) | 1995-03-08 |
GB9210839D0 (en) | 1992-07-08 |
WO1993023401A1 (en) | 1993-11-25 |
CN1094046A (zh) | 1994-10-26 |
JPH07506591A (ja) | 1995-07-20 |
CA2136196A1 (en) | 1993-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9302957A (es) | Compuestos de xantina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
DE69328192T2 (de) | Injizierbare Arzneizubereitungen enthaltend Taxanderivate | |
ES8705393A1 (es) | Un procedimiento para preparar un derivado de pirazol (como divisional de la solicitud de patente de invencion n 543.046, presentada el 10.5.85) | |
PT97888A (pt) | Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem | |
ES2114931T3 (es) | Nuevos esteres esteroidales. | |
DK157678C (da) | Analogifremgangsmaade til fremstilling af amider af hydroxyfenylalkylaminoaetanoler eller terapeutisk acceptable salte deraf samt acetofenonderivat til anvendelse som udgangsmateriale ved fremgangsmaaden | |
MY103233A (en) | Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions | |
ES2035824T3 (es) | Procedimiento para preparar compuestos profarmacos y preparaciones que los contienen. | |
ATE111912T1 (de) | Xanthinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate. | |
MX9307946A (es) | Derivados de amina secundaria ciclica, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso. | |
DK0559690T3 (da) | 8-en-19,11Beta-broholdige steroider, deres fremstilling og farmaceutiske præparater, som indeholder dem | |
DE69426908D1 (de) | Derivate der Phosphonsäure, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten | |
SE8403268D0 (sv) | 1,4-dihydropyridin-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen | |
DE3870167D1 (de) | N-(vinblastinoyl-23)-derivate von 1-aminomethylposphonsaeure, verfahren zu ihrer herstellung und sie enthaltende arzneimittel. | |
ES2053755T3 (es) | Un procedimiento para preparar compuestos heterociclicos. | |
ES2060592T3 (es) | Un tioester y su uso en la preparacion de composiciones farmaceuticas para el tratamiento de los sindromes de isquemia y reperfusion. | |
HU9203400D0 (en) | Method for producing new n-substituted n-nitroso-amino-aceto-nitryl derivatives and pharmaceutical derivatives containing them | |
SE8603589L (sv) | Metylendioxifenantren- och stilbenderivat | |
SE9203824L (sv) | Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma | |
DE68906827T2 (de) | Phenothiazinderivate, deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. | |
EP0402469A4 (en) | Catechol compounds, process for their preparation and pharmaceutical preparation containing same | |
ES2053544T3 (es) | Un procedimiento para la preparacion de nuevos derivados de indol tetraciclicos. | |
FI860098A (fi) | Nya piperazinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner som innehaoller dessa foereningar som aktiv ingrediens. | |
DE69011235D1 (de) | Derivate von N-(Vincristinyl-23) und N-(Noranhydro-5-vinblastinyl-23) von Amino-1-methylphosphonsäure, ihre Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. | |
ATE145647T1 (de) | Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen |